PM
Prosight Management’s Gyre Therapeutics GYRE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-301,678
| Closed | -$1.3M | – | 41 |
|
2020
Q3 | $1.3M | Buy |
301,678
+53,628
| +22% | +$231K | 0.62% | 34 |
|
2020
Q2 | $1.46M | Sell |
248,050
-134,850
| -35% | -$792K | 0.63% | 36 |
|
2020
Q1 | $1.67M | Sell |
382,900
-8,994
| -2% | -$39.3K | 0.78% | 31 |
|
2019
Q4 | $2.67M | Sell |
391,894
-166,265
| -30% | -$1.13M | 1.17% | 22 |
|
2019
Q3 | $2.74M | Buy |
558,159
+11,067
| +2% | +$54.3K | 1.52% | 22 |
|
2019
Q2 | $4.03M | Buy |
547,092
+62,892
| +13% | +$464K | 2.03% | 18 |
|
2019
Q1 | $3.93M | Buy |
484,200
+17,300
| +4% | +$140K | 1.72% | 23 |
|
2018
Q4 | $3.68M | Buy |
466,900
+230,342
| +97% | +$1.82M | 1.9% | 21 |
|
2018
Q3 | $2.55M | Buy |
+236,558
| New | +$2.55M | 1.42% | 24 |
|